Consensus EPS · Q2 2026
$1.03
Consensus revenue · Q2 2026
$5.3B
Analysts
10
Expected report
Jul 29, 2026
What to watch
- Analyst ratings: Mixed
Analyst consensus
Based on estimates from 10 analysts.
| Metric | Low | Consensus | High |
|---|---|---|---|
| Revenue | $5.2B | $5.3B | $5.3B |
| EPS | $1.01 | $1.03 | $1.05 |
| EBITDA | $963M | $972.2M | $981.5M |
| EBIT | $797.4M | $805.1M | $812.8M |
| Net income | $463.2M | $472.3M | $481.4M |
- Revenue$5.3B
- EPS$1.03
- EBITDA$972.2M
- EBIT$805.1M
- Net income$472.3M
Historical beat/miss
Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.
| Period | Rev. actual | Rev. est. | Rev. surprise | EPS actual | EPS est. | EPS surprise |
|---|---|---|---|---|---|---|
| Q1 2026 | $5.1B | $5B | +1.8% | $0.99 | $1.04 | -5.3% |
- Q1 2026+1.8%-5.3%
Estimate revisions
How analyst consensus estimates have changed over the past 90 days.
Revision trends appear once we have collected at least two daily snapshots for this period.
Community vs analysts
See how the TickerLeague crowd's forecast stacks up against Wall Street.
Be the first to predict
No community consensus for GE HealthCare (GEHC) Q2 2026 yet. Make a prediction to start the crowd forecast.
Analyst price target
Based on price targets from 4 analysts.
- Low
- $65.00
- Consensus
- $78.58
- Median
- $80.00
- High
- $90.00
- Current
- $61.41
- Upside
- +28.0%
Upside calculated vs most recent trading price of $61.41.
Analyst ratings
Consensus: Buy — based on 18 analyst ratings.
24-month trend
Recent analyst actions
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 16, 2026 | UBS | maintain | Neutral | Neutral |
| May 21, 2026 | UBS | upgrade | Sell | Neutral |
| Apr 30, 2026 | Wells Fargo | maintain | Overweight | Overweight |
| Apr 30, 2026 | JP Morgan | maintain | Neutral | Neutral |
| Apr 30, 2026 | Goldman Sachs | downgrade | Buy | Neutral |
| Apr 30, 2026 | Evercore ISI Group | maintain | Outperform | Outperform |
| Apr 30, 2026 | Citigroup | maintain | Neutral | Neutral |
| Apr 30, 2026 | Barclays | maintain | Equal Weight | Equal Weight |
| Apr 29, 2026 | BTIG | maintain | Buy | Buy |
| Apr 21, 2026 | BTIG | maintain | Buy | Buy |
- Jul 16, 2026UBSNeutral
- May 21, 2026UBSNeutral
- Apr 30, 2026Wells FargoOverweight
- Apr 30, 2026JP MorganNeutral
- Apr 30, 2026Goldman SachsNeutral
- Apr 30, 2026Evercore ISI GroupOutperform
- Apr 30, 2026CitigroupNeutral
- Apr 30, 2026BarclaysEqual Weight
- Apr 29, 2026BTIGBuy
- Apr 21, 2026BTIGBuy
Frequently asked questions
GE HealthCare (GEHC) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.